Compare Kotak Healthcare Fund vs ICICI Prudential Healthcare Fund
Kotak Healthcare Fund
EquitySectoral-Pharma
ICICI Prudential Healthcare Fund
EquitySectoral-Pharma
Risk
Very High
Very High
Rating
-
4.0
Min SIP Amount
₹100
₹100
Expense Ratio
2.54
2.07
NAV
₹16.99
₹44.81
Fund Started
20 Nov 2023
25 Jun 2018
Fund Size
₹825.14 Cr
₹6861.20 Cr
Exit Load
0.5% for redemption within 30 Days
Exit load of 1% if redeemed within 15 days.
1 Year
18.62%
2.11%
3 Year
-
19.35%
5 Year
-
13.95%
Equity
98.69%
98.91%
Cash
1.31%
1.09%
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 13.21% |
Divi's Laboratories Ltd. | 9.35% |
Molbio Diagnostics Ltd. | 5.08% |
Torrent Pharmaceuticals Ltd. | 4.65% |
Acutaas Chemicals Ltd. | 4.17% |
Max Healthcare Institute Ltd. | 3.61% |
Cipla Ltd. | 3.26% |
Park Medi World Ltd. | 3.17% |
Gland Pharma Ltd. | 3.16% |
Yatharth Hospital & Trauma Care Services Ltd. | 3.12% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.49% |
Dr. Reddy's Laboratories Ltd. | 9.73% |
Cipla Ltd. | 5.79% |
Biocon Ltd. | 5.33% |
Mankind Pharma Ltd. | 5.04% |
Alkem Laboratories Ltd. | 4.81% |
Medplus Health Services Ltd. | 4.31% |
Cohance Lifesciences Ltd. | 4.06% |
Divi's Laboratories Ltd. | 3.78% |
Syngene International Ltd. | 3.50% |
Name
-
-
Start Date
-
-
Description
The scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly Pharma, Healthcare, and allied sectors.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
20 Nov 2023
25 Jun 2018
